How to Scale Up Scientifically

The author reviews dimensional analysis as a straight-forward approach to scale up.

External Link - article-150848.pdf

Articles in this issue

almost 21 years ago

Article

Developing and Using Analytical Methods to Achieve Quality by Design and Efficiency in Drug Development

almost 21 years ago

Article

Scale Up of Liquid and Semisolid Manufacturing Processes

almost 21 years ago

Article

Scale Up of Powder-Blending Operations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Aging process, rejuvenation anti-aging skin procedures old and young concept | Image Credit: © leszekglasner - stock.adobe.com

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

ByPatrick Lavery

December 4th 2025

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

ByJayaprakash Nair

December 3rd 2025

Medical banner Pulmonary fibrosis on blue background | Image Credit: © mi_viri -stock.adobe.com

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

BySusan Haigney

December 2nd 2025

Hand holding a stylus over a tablet with futuristic risk management icons such as warning signs, data charts, and safety symbols on a dark background. | Image Credit: ©ImageFlow -stock.adobe.com

How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems

BySusan Haigney

December 2nd 2025

Fluorescent Imaging immunofluorescence of cancer cells growing in 2D with nuclei in blue, cytoplasm in red and DNA damage foci in green | Image Credit: ©drimafilm - stock.adobe.com

Live Cell High-Content Imaging Is Driving Drug Discovery

ByCheryl Barton

December 1st 2025

How to Scale Up Scientifically

Articles in this issue

Newsletter

Related Content

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems

Live Cell High-Content Imaging Is Driving Drug Discovery

Trending on Pharmaceutical Technology

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

FDA Deploys Agentic AI Capabilities for Agency Staff

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

PharmTech Weekly News Roundup – Week of December 1, 2025